As of December 2024, CytoDyn has a market cap of $113.51M. This makes CytoDyn the world's 19455th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $158.30M | -15.00% |
2023 | $186.23M | -13.04% |
2022 | $214.16M | -76.77% |
2021 | $921.84M | -81.63% |
2020 | $5.02B | 439.00% |
2019 | $931.15M | 112.77% |
2018 | $437.64M | -14.55% |
2017 | $512.13M | -17.91% |
2016 | $623.87M | -12.99% |
2015 | $716.99M | -33.04% |
2014 | $1.07B | 9.52% |
2013 | $977.71M | -22.79% |
2012 | $1.27B | -54.52% |
2011 | $2.78B | 32.89% |
2010 | $2.10B | 31.58% |
2009 | $1.59B | 307.14% |
2008 | $391.08M | 44.83% |
2007 | $270.03M | -58.57% |
2006 | $651.81M | - |